Literature DB >> 27460528

Pediatric Miller Fisher Syndrome Complicating an Epstein-Barr Virus Infection.

Céline Communal1, Anne Filleron2, Sandrine Baron-Joly1, Randa Salet1, Tu-Anh Tran3.   

Abstract

BACKGROUND: Miller Fisher syndrome, a variant of Guillain-Barré syndrome, is an acute inflammatory demyelinating polyradiculoneuropathy that may occur weeks after a bacterial or viral infection. Campylobacter jejuni and Haemophilus influenzae are frequently reported etiological agents. PATIENT DESCRIPTION: We describe a boy with Miller Fisher syndrome following Epstein-002DBarr virus primary infectious mononucleosis. He presented with bilateral dysfunction of several cranial nerves and hyporeflexia of the limbs but without ataxia. Miller Fisher syndrome was confirmed by the presence of anti-GQ1b antibodies in a blood sample. Epstein-Barr virus was identified by polymerase chain reaction and serology.
CONCLUSION: Epstein-Barr virus should be considered as a Miller Fisher syndrome's causative agent. The physiopathology of this condition may involve cross-reactive T-cells against Epstein-Barr virus antigens and gangliosides.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epstein-Barr virus; Guillain-Barré syndrome; Infectious mononucleosis; Miller-Fisher syndrome; pediatric; polyneuropathy

Mesh:

Year:  2016        PMID: 27460528     DOI: 10.1016/j.pediatrneurol.2016.06.018

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

Review 1.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

2.  An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report.

Authors:  Le Chang; Jing Xiong; Yuying Xue; Jie Wang; Xurong Zhu; Xuejiao Zheng; Xiaoyu Gao; YuE Yan; Jiaduo Hao; Hehuan Zhao; Zhengli Di
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.